Skip to main content

Table 2 Clinical data comparing 81 cases of respiratory tract infections caused by M. pneumoniae with different in vitro susceptibility to macrolides

From: Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016

 

Macrolide-resistant M. pneumoniae group (n = 53)

Macrolide-susceptible M. pneumoniae group (n = 28)

Male

22 (41.5%)

11 (39.2%)

Clinical Symptoms

 Temperature (°C)

38.12

37.96

 Cough

39 (73.6%)

18 (64.3%)

 Sputum

33 (62.3%)

(53.8%)

 Headache

16 (30.2%)

11 (39.3%)

 Chest pain

3 (5.7%)

0

Leukocyte count (109 cells/L)

8.44

8.71

Antibiotics usage before detection

14 (26.4%)

10 (35.7%)